NovoCure Ltd (NASDAQ: NVCR) has recently experienced extremely important negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, its longer term price trend turned down, and negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
NovoCure has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. NovoCure has a very low Appreciation Score of 9 but a good Power Rating of 74, leading to the Negative Value Trend Rating.
Recent Price Action
NovoCure Ltd (NASDAQ: NVCR) stock declined slightly by -0.8% on 2/28/25. The stock closed at $19.07. Moreover, this decline was accompanied by exceptionally high trading volume at 254% of normal. The stock has declined -11.9% during the last week but has been exceptionally strong relative to the market over the last nine months.
Be the first to comment